Compare MREO & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MREO | DDD |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 373.9M |
| IPO Year | N/A | N/A |
| Metric | MREO | DDD |
|---|---|---|
| Price | $0.46 | $2.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $3.90 | ★ $4.75 |
| AVG Volume (30 Days) | ★ 21.9M | 5.3M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $500,000.00 | ★ $391,651,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | $1.31 |
| P/E Ratio | ★ N/A | $21.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.20 | $1.32 |
| 52 Week High | $3.26 | $5.00 |
| Indicator | MREO | DDD |
|---|---|---|
| Relative Strength Index (RSI) | 31.93 | 45.82 |
| Support Level | $0.42 | $2.47 |
| Resistance Level | $0.78 | $2.89 |
| Average True Range (ATR) | 0.08 | 0.20 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 10.72 | 4.86 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.